Differential Impacts of Adiponectin on Low-grade Albuminuria Between Obese and Nonobese Persons Without Diabetes

Overview

Journal J Clin Hypertens (Greenwich)

Specialty Cardiology & Vascular Diseases

Date 2007 Oct 6

PMID 17917505

Citations 32

Authors

Yuichiro Yano

Satoshi Hoshide

Joji Ishikawa

Toru Hashimoto

Kazuo Eguchi

Kazuyuki Shimada

Kazuomi Kario

Affiliations

Soon will be listed here.

Abstract

The goal of this study was to examine the association between adiponectin and low-grade albuminuria in nondiabetic persons and whether it differed between obese and nonobese individuals. Urinary albumin excretion (UAE) was assessed by overnight collection in 157 participants. Overall, as anticipated, 24-hour systolic blood pressure and fasting glucose levels were independent determinants of UAE (beta=0.254 and 0.176, respectively, P<.05). In obese persons (body mass index [BMI] >/=25 kg/m(2); n=63), adiponectin value was a significant negative determinant of UAE (beta=-0.256, P<.05) independent of blood pressure and glucose levels, whereas in nonobese participants (n=94) it was not. In an analysis of BMI and the median value of adiponectin (9.9 microg/mL), UAE was found to be significantly higher in obese persons with low adiponectin levels than in obese persons with high adiponectin levels (9.20 vs 5.11 microg/min; P<.05), even after adjustment for age, sex, blood pressure level, and glucose level. There was an inverse association between adiponectin and low-grade albuminuria in obese nondiabetic persons.

Citing Articles

The Impact of Early-Stage Chronic Kidney Disease on Weight Loss Outcomes After Gastric Bypass.

Pereira J, Pereira P, Andrade S, Pereira S, Nora M, Guimaraes M Obes Surg. 2023; 33(12):3767-3777.

PMID: 37816974 PMC: 10687110. DOI: 10.1007/s11695-023-06862-2.

Renal Dysfunction Phenotypes in Patients Undergoing Obesity Surgery.

Pereira P, Pereira J, Braga P, Pereira S, Nora M, Guimaraes M Biomolecules. 2023; 13(5).

PMID: 37238660 PMC: 10216106. DOI: 10.3390/biom13050790.

Obesity and renal disease: Benefits of bariatric surgery.

Ardiles L Front Med (Lausanne). 2023; 10:1134644.

PMID: 36926320 PMC: 10011092. DOI: 10.3389/fmed.2023.1134644.

Adiponectin in Chronic Kidney Disease.

Przybycinski J, Dziedziejko V, Puchalowicz K, Domanski L, Pawlik A Int J Mol Sci. 2020; 21(24).

PMID: 33317050 PMC: 7764041. DOI: 10.3390/ijms21249375.

Irisin and Visfatin Predicts Severity of Diabetic Nephropathy.

Mageswari R, Sridhar M, Nandeesha H, Parameshwaran S, Vinod K Indian J Clin Biochem. 2019; 34(3):342-346.

PMID: 31391726 PMC: 6660529. DOI: 10.1007/s12291-018-0749-7.

References

Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N . Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000; 96(5):1723-32. View

. Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res. 2007; 29 Suppl:S1-105. DOI: 10.1291/hypres.29.s1. View

Tsioufis C, Dimitriadis K, Chatzis D, Vasiliadou C, Tousoulis D, Papademetriou V . Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol. 2005; 96(7):946-51. DOI: 10.1016/j.amjcard.2005.05.052. View

Matsuzawa Y, Funahashi T, Kihara S, Shimomura I . Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2003; 24(1):29-33. DOI: 10.1161/01.ATV.0000099786.99623.EF. View

Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y . Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100(25):2473-6. DOI: 10.1161/01.cir.100.25.2473. View

Pilz S, Horejsi R, Moller R, Almer G, Scharnagl H, Stojakovic T . Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab. 2005; 90(8):4792-6. DOI: 10.1210/jc.2005-0167. View

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View

Wiecek A, Kokot F, Chudek J, Adamczak M . The adipose tissue--a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant. 2002; 17(2):191-5. DOI: 10.1093/ndt/17.2.191. View

Kramer H, Jacobs Jr D, Bild D, Post W, Saad M, Detrano R . Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension. 2005; 46(1):38-43. DOI: 10.1161/01.HYP.0000171189.48911.18. View

10.

Choo V . WHO reassesses appropriate body-mass index for Asian populations. Lancet. 2002; 360(9328):235. DOI: 10.1016/S0140-6736(02)09512-0. View

11.

Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H . Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004; 110(1):32-5. DOI: 10.1161/01.CIR.0000133312.96477.48. View

12.

Pascual J, Rodilla E, Gonzalez C, Perez-Hoyos S, Redon J . Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension. 2005; 45(6):1125-30. DOI: 10.1161/01.HYP.0000167151.52825.11. View

13.

Kadowaki T, Yamauchi T . Adiponectin and adiponectin receptors. Endocr Rev. 2005; 26(3):439-51. DOI: 10.1210/er.2005-0005. View

14.

Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K . Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006; 116(7):1784-92. PMC: 1483172. DOI: 10.1172/JCI29126. View

15.

Kaneda R, Kario K, Hoshide S, Umeda Y, Hoshide Y, Shimada K . Morning blood pressure hyper-reactivity is an independent predictor for hypertensive cardiac hypertrophy in a community-dwelling population. Am J Hypertens. 2005; 18(12 Pt 1):1528-33. DOI: 10.1016/j.amjhyper.2005.06.015. View

16.

Redon J . Urinary albumin excretion: lowering the threshold of risk in hypertension. Hypertension. 2005; 46(1):19-20. DOI: 10.1161/01.HYP.0000169154.94803.35. View

17.

Rowley K, ODea K, Best J . Association of albuminuria and the metabolic syndrome. Curr Diab Rep. 2003; 3(1):80-6. DOI: 10.1007/s11892-003-0058-1. View

18.

Levey A, Coresh J, Balk E, Kausz A, Levin A, Steffes M . National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003; 139(2):137-47. DOI: 10.7326/0003-4819-139-2-200307150-00013. View

19.

El-Atat F, Stas S, McFarlane S, Sowers J . The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol. 2004; 15(11):2816-27. DOI: 10.1097/01.ASN.0000133698.80390.37. View

20.

Agewall S, Bjorn F . Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men. Atherosclerosis. 2002; 164(1):161-6. DOI: 10.1016/s0021-9150(02)00056-4. View